Monocytic microRNA profile associated with coronary collateral artery function in chronic total occlusion patients

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Genomics

Background:

• An extensive collateral artery network improves survival after cardiac events.
• Identifying molecular regulators of collateral artery growth is crucial for cardiovascular health.
• MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various biological processes.

Purpose of the Study:

• To identify specific cellular microRNAs (miRNAs) that play a role in the development of coronary collateral arteries.
• To investigate the association between miRNA expression profiles in monocytes and collateral artery capacity in patients with chronic total coronary occlusion (CTO).

Main Methods:

• MiRNA profiling using next-generation sequencing was performed on monocytes from CTO patients categorized by collateral flow index (CFIp) into high (n=14) and low (n=12) capacity groups.
• Monocytes were analyzed in various states: freshly isolated, cultured without stimulant, or stimulated with lipopolysaccharide, interleukin 4, transforming growth factor beta-1, or interferon gamma.
• Validation of miRNA expression was conducted using real-time polymerase chain reaction (RT-PCR), and pathway analysis (Ingenuity Pathway Analysis) was used to predict gene targets and associated signaling pathways.

Main Results:

• Significant differences in miRNA expression patterns were observed between patients with high and low collateral capacity.
• Expression of miR339-5p was significantly decreased in all stimulated monocyte phenotypes of patients with low collateral capacity and correlated with CFIp values.
• Pathway analysis indicated a significant association with the STAT3 signaling pathway, suggesting its potential regulatory role in collateral vessel growth.

Conclusions:

• This study identifies a novel association between miR339-5p and coronary collateral function in patients with CTO.
• Decreased miR339-5p expression in monocytes may contribute to impaired collateral artery development.
• Further research into modulating miR339-5p and its effects on the STAT3 pathway is warranted to explore therapeutic strategies for enhancing collateral vessel growth.